INC: Ipilimumab + Nivolumab + Ciforadenant in RCC

Clinical Trial Grant

Duke Scholars

Principal Investigator Daniel James George Medicine, Medical Oncology

Awarded By

The University of Texas MD Anderson Cancer Center

Start Date

October 3, 2023

End Date

April 2, 2027

Awarded By

The University of Texas MD Anderson Cancer Center

Start Date

October 3, 2023

End Date

April 2, 2027